“But he’s definitely in a better place in terms of his form and how he looks. He’s smiling and seems happy, which is fantastic for everyone connected with Rangers.” Image:Morelos has scored 84 goals in just 154 games for Rangers Steven Gerrard says Alfredo Morelos is gunning for the Champions League after the Rangers record-breaker rediscovered his hunger for goals.The Colombian has had a lean start to the campaign but two strikes in his last two Europa League outings have seen him move past Ibrox great Ally McCoist to become the club’s all-time top scorer in continental competition with 22 goals.- Advertisement – – Advertisement – – Advertisement – All those goals have come in UEFA’s second-tier tournament but Gerrard knows the 24-year-old has ambitions to go even higher.He said: “Yes, he was very happy after the game about his record-breaking (achievement). I think he’s got his hunger back and you can see it in his eyes, he wants to go and score more goals in the competition.“I know he’s got dreams and aspirations of playing in the Champions League one day, which is good for him.” Morelos became the first player to reach double figures in the Europa League for Rangers with his goal against Benfica, and he has now netted 84 times in just 154 games for the club.Gerrard added: “In terms of where he’s at, the goals are back, the hunger is back, the sharpness is back.“I don’t really like comparing him to (the Alfredo) of old because it’s about the now and what he is offering moving forward.- Advertisement –
Russian soldier shoots dead eight fellow servicemen- Advertisement – – Advertisement –
To stay afloat, cinema chains have been renegotiating deals with lenders and landlords and developing creative ways to generate revenue.Most major cinemas are now offering up cheaper private theater rentals as a way to entice in reluctant moviegoers. Others have transformed parking lots into concert venues, launched trivia nights and even negotiated deals with local colleges to rent out the space for in-person learning. Noam Galai | Getty Images Entertainment | Getty Images Movie theater chains got some good news on Monday morning — trial data indicated Pfizer and BioNTech’s Covid-19 vaccine is more than 90% effective.- Advertisement – The news sent AMC shares soaring as high as 80% in premarket trading before settling around a 50% gain after the opening bell. Cinemark shares were trading up about 52%, while Marcus Theatres and IMAX were gaining about 18% in early morning trading.The coronavirus pandemic has battered theaters since March, crunching their bottom lines and threatening to push chains big and small towards bankruptcy. As of the close on Friday, Cinemark shares were down 74%, AMC was down 66% and Marcus was down 75%.Last week, these movie theater chains reported third-quarter results, signaling yet another period of losses.- Advertisement – With movie theaters hauling in less than a quarter of the revenue they were generating last year, AMC and B&B Theatres, the sixth-largest cinema chain, have both warned of the possibility of bankruptcy. Studio Movie Grill, a Dallas-based dine-in theater chain, filed for Chapter 11 bankruptcy protection last month.The hope is that with a vaccine, Covid-19 cases will decrease substantially and audiences will be more willing to return to theaters. This, in turn, will give studios confidence to keep major film titles on the calendar. Without fresh content, moviegoers won’t return in droves.Still, a vaccine might not be widely available to the public until mid-2021. So, while the news is promising, it does not fix the near term issues that movie theaters are facing.- Advertisement – – Advertisement –
Braunwyn Windham-Burke and husband Sean Burke have been married for more than 20 years, but it hasn’t always smooth sailing for the Real Housewives of Orange County couple.While Bravo fans met Braunwyn in 2019 when she joined the cast of RHOC for season 14, she started seeing Sean when she was just 18 years old.- Advertisement – Before season 15 of RHOC started airing in October 2020, Braunwyn sparked split speculation as she promoted a Zoom session with a divorce specialist.Scroll through for more on Braunwyn and Sean’s ups and downs: – Advertisement – “I learned [doing the show] that I can’t always rely on my husband,” she explained in a 2019 interview. “I’ve been with my husband since I was 18, so I had to stand on my own two feet for the first time in my entire adult life. And that was not always easy.”Braunwyn and Sean tied the knot in 2000 and went on to welcome seven kids: Bella, Rowan, Jacob, twins Caden and Curren, Koa and Hazel. Before the pair welcomed their twins and youngest daughters, however, they actually separated for a short period of time.“We fought for our family because Sean and I almost got divorced,” Braunwyn recalled on the RHOC aftershow in November 2019. “We’ve been through infidelity. We’ve gone down this road and Sean and I came back stronger.”- Advertisement – While they welcomed four more kids post-split, Braunwyn ruled out welcoming baby No. 8 in 2020, revealing that she underwent two years of IVF to have the couple’s youngest daughter.“We worked very hard for this little one, 2 years of IVF and many losses to get her, but when I look at her huge smile, her eyes that light up and her adorable laugh I can tell you, it’s all worth it,” Braunwyn gushed via Instagram. “She’s the easiest baby we’ve ever had, is best friends with her sister and loves to just follow the others around. I’m so grateful for you, thank you for being a part of our family.”- Advertisement –
Jun 24, 2005 (CIDRAP News) – As poultry were being culled in China and Vietnam to prevent further spread of avian influenza outbreaks this week, international experts were visiting both countries to better understand how the H5N1 virus is behaving.Ducks in central Vietnam were being culled after authorities discovered that one-fifth of the waterfowl in Quang Tri province carry the H5N1 virus, China’s Xinhau news service reported today, basing the story on a Vietnamese newspaper, Saigon Liberation. More than 23,000 birds have already been culled in 38 infected flocks, with another 144 flocks untested, Xinhua reported.As many as 120,000 to 150,000 birds may be culled, according to a report today by the Vietnamese news service Thanh Nien News, which also cited the Saigon Liberation as its source.In response to the outbreaks, the Agriculture and Rural Development Ministry extended an existing ban on egg incubation for breeding poultry and building new waterfowl or quail flocks through February 2006, according to the Vietnam News Service (VNS). In addition, the country’s state bank has asked that commercial banks refuse loans to farmers and businesses that produce breeding poultry and waterfowl, VNS reported today.This is the second outbreak in Vietnamese poultry in about a week. Prior to that, the country had been free of bird outbreaks since April, Xinhua reported. However, human cases of H5N1 infection have continued without a major break since mid-December 2004.Possible and confirmed human H5N1 infections in Vietnam are the focus of intense study by a visiting team of experts from Britain, Hong Kong, Japan, and the United States, according to a Canadian Press (CP) report today. The team of about half a dozen virologists and epidemiologists is investigating whether the H5N1 virus has changed in ways that make a flu pandemic more likely.The team is working in Vietnam at the government’s request, Maria Cheng, a World Health Organization (WHO) spokeswoman, told the CP.Their tasks include studying clusters of cases to determine the extent of human-to-human transmission and analyzing tests on hundreds of stored human blood samples that may indicate scores of undetected human H5N1 infections, the CP reported.Those findings are questionable because they relied on the Western blot test, which is not the gold standard for flu testing, the CP story said.Authorities are negotiating to transfer the blood samples to a site where appropriate tests can be performed—a lab with the biosafety rating to conduct neutralization assays considered the gold standard for flu testing, the CP reported.In China, international experts sent by the WHO and the Food and Agriculture Organization (FAO) were studying the H5N1 outbreak in Qinghai province this week and recently received approval to do the same in neighboring Xinjiang province, the International Herald Tribune reported yesterday.China has had three avian outbreaks of H5N1 in recent weeks, including one this week that involved the deaths of 180 ducks and geese, according to its reports to the World Organization for Animal Health (OIE). In all, at least 1,490 birds were culled, according to a Jun 21 story by Agence France-Presse (AFP).Authorities are also pressuring China for details of farmers’ reported use of the human antiviral drug amantadine to control and prevent poultry outbreaks of H5N1. Scrutiny has extended to questions over whether China has used oseltamivir, one of a newer class of human antiviral drugs, on poultry, the CP reported on Jun 23.The WHO asked China to investigate whether farmers have used oseltamivir in poultry, and the FAO has urged China to prevent such use, the CP story said. Several countries are stockpiling oseltamivir for use in the event of a flu pandemic. Current strains of H5N1 are resistant to amantadine, but it could also be useful in a pandemic, depending on the nature of the pandemic virus, experts say.A spokesman for the company that makes oseltamivir, Roche, said the company doesn’t sell the product to agro-chemical businesses, the CP story said.The report quoted WHO spokesman Dick Thompson as saying, “It’s clear to us that the [Chinese] Ministry of Health shares our concerns about this and they understand the importance of . . . the possible use of this antiviral in agriculture, that it might force or speed [development of] a resistant strain.”
Dec 29, 2005 (CIDRAP News) – China has recorded its seventh human case of H5N1 avian influenza, involving a 41-year-old factory worker who died Dec 21, according to the Chinese news service Xinhua.The victim was a woman surnamed Zhou who lived in Sanming City in the eastern province of Fujian, Xinhua reported today. She became ill with fever and pneumonia on Dec 6 and was hospitalized 2 days later.Samples from the patient initially tested negative for the virus, but later tests by provincial and national laboratories were positive, the report said.The Chinese Ministry of Health said no poultry outbreak of H5N1 was reported near where Zhou lived, according to Xinhua. The report did not suggest how she might have contracted the virus.People who were in close contact with the patient are under medical observation, and no problems have been seen so far, the report said.China’s previous six human cases have been widely scattered, including two deaths in Anhui province and nonfatal cases in Hunan, Liaoning, and Jiangxi provinces, plus Guangxi Zhuang Autonomous Region, Xinhua said. The last previous case was reported Dec 16 in a 35-year-old man from Jiangxi; the outcome has not yet been announced.The World Health Organization’s current overall human case count stands at 141, including 73 deaths, not counting the Chinese case reported today.A trial of a human H5N1 vaccine developed in China began Dec 21 with six volunteers, Xinhua reported. “The whole trials will need nine months of tests, but initial results are expected within the first three,” the story said.China has reported 31 outbreaks of H5N1 avian flu in poultry so far this year, according to Xinhua. Twenty-six of those have occurred since Oct 19, an Associated Press report said.
In recent years, epidemics have occurred in India and on various Indian Ocean islands, including Comorros, Mauritius, Reunion, and Seychelles. A major epidemic struck Reunion, a French territory, between March 2005 and June 2006, sickening an estimated 266,000 people, about 35% of the population, according to Eurosurveillance. Several hundred cases occurred in France during the Reunion epidemic, but nearly all were linked to the island epidemic, the report says. Eurosurveillance reporthttp://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=3260 CDC information on chikungunyahttp://www.cdc.gov/chikungunya/ The Eurosurveillance report does not say whether the index case-patient reported mosquito bites, but an online news report by the journal Nature says authorities think the virus “spread among the dense population of tiger mosquitoes” after the man’s illness. There is a possibility that the same thing could happen in the United States, since the two mosquito species that can spread the virus are found in the Southeast, according to an official with the US Centers for Disease Control and Prevention (CDC). But he said the likelihood of that is “relatively low.” Flahault suggested that the very dense mosquito population in and around Ravenna had spurred the outbreak, according to the story. He said the Italian climate has grown warmer and more humid, favoring the proliferation of mosquitoes. Chikungunya usually causes fever, headache, fatigue, nausea, vomiting, muscle and joint pain, and a rash, according to the CDC. The disease is not life-threatening. Symptoms typically last a few days to 2 weeks, but fatigue or joint pain sometimes lingers for weeks to months, the CDC says. “The current outbreak of chikungunya fever in northeastern Italy . . . marks the first recorded occasion that this virus has been transmitted by mosquitoes within Europe,” the report states. The report says A albopictus is found in several other European countries, including Albania, France, Belgium, Montenegro, Switzerland, Greece, Spain, Croatia, the Netherlands, Slovenia, Bosnia, Herzegovina, and possibly more, suggesting a potential for further spread of the disease. Could disease spread to the US?The United States has recorded some chikungunya cases among returning travelers, but no transmission of the disease, according to Dr. Ned Hayes, a medical epidemiologist with the CDC’s Division of Vector-Borne Infectious Diseases in Fort Collins, Colo. But he said the two mosquitoes that can spread chikungunya—A albopictus and Aedes aegypti—are found in the southeastern United States. “For chikungunya to be transmitted in the US, you need to have a viremic person or mosquito introduction in an area where both susceptible persons and the predominant mosquito vector are present,” Hayes said. “Both those conditions exist in the US, so I think the importation of chikungunya is a concern.” Epidemics described as cyclicalThe World Health Organization (WHO) reports that major chikungunya epidemics “appear and disappear cyclically,” with quiet periods usually lasting 7 to 8 years but sometimes as long as 20 years. Chikungunya clinically resembles dengue fever, which is widespread in the tropics, according to the WHO. The chikungunya virus was first identified in 1953 during an epidemic in Tanzania, according to the CDC. Europe has had scattered cases of chikungunya before, mainly in travelers from parts of Africa and Asia where the disease is established. But the outbreak this summer in Italy’s Ravenna province was spread by mosquitoes, according to a report published Sep 6 by Eurosurveillance Weekly. The name “chikungunya” is Swahili for “that which bends up,” a reference to the stooped posture associated with joint pain. There is no vaccine or specific antiviral treatment for the illness, which is caused by a virus of the genus Alphavirus. But the risk of indigenous transmission is “probably relatively low in the continental United States,” mainly because of socioeconomic and lifestyle differences that tend to limit the spread of mosquito-borne viruses like chikungunya, dengue, and yellow fever, Hayes said. For example, air conditioning and window screens help protect people from heavy exposure to mosquitoes, he explained. Hayes said the key message is that people should be aware of mosquito-borne illness risks, especially when traveling, and take steps to protect themselves from bites. Travelers who have a fever on returning to the United States should seek medical attention and inform health authorities of any infection. Eurosurveillance says the disease was mild and self-limiting in most patients, but joint pain was intense and often persisted after the fever abated. One patient, an 83-year-old man with severe underlying health problems, died. Antoine Flahault, who coordinates French research on chikungunya, called the Italian outbreak a “world first” outside the tropics, according to a Sep 7 BBC News report. Writing in the journal Quotidien du Medecin, he said the virus’s movement into Europe was “worrying without being alarming.” Italy reports 166 casesIn the Italian outbreak, officials recorded 166 cases, most of them in two neighboring villages, according to Eurosurveillance. The outbreak is believed to have started after a man from India fell ill while visiting one of the villages in late June. The epidemic peaked in the third week of August. “It’s possible, if the virus should become endemic in, say, the southeastern US, that it could provide a locus for spread to other parts of the country, but I wouldn’t think it would spread like West Nile virus,” he said. Birds have helped spread West Nile across the continent since the disease emerged in New York City in 1999. Sep 10, 2007 (CIDRAP News) – A recent outbreak of the debilitating tropical disease known as chikungunya fever in northern Italy apparently marks the mosquito-borne infection’s first foothold in Europe, according to European health authorities. Chikungunya does not commonly spread from person to person, Hayes said. However, it can spread from a pregnant woman to her fetus, and it could probably be spread via blood donated by an infected person, he said. But infected people have the virus in their blood for only a short time. “We don’t even know why West Nile disease [another mosquito-borne viral illness] became endemic in North America but not in Europe, even though the virus and the vector are present on both continents,” Evelyn Depoortere, an epidemiologist at the European Centre for Disease Prevention and Control in Stockholm, told Nature. However, areas where dengue transmission already occurs or is possible may be more vulnerable to chikungunya, Hayes said. Such areas include parts of Florida and Texas, plus Puerto Rico and the US Virgin Islands. But scientists quoted in the Nature story said they don’t know enough to predict whether the disease will spread to other European countries that have A albopictus. WHO Southeast Asia information sheet on chikungunyahttp://www.who.int/mediacentre/factsheets/fs327/en/ See also: If chikungunya did gain a toehold in the United States, it would be unlikely to spread across the continent, in Hayes’s opinion. Although the Italian outbreak was associated with A albopictus, the primary vector for chikungunya is A aegypti, the yellow fever mosquito, the CDC says. It was not until the end of August that investigators zeroed in on the diagnosis of chikungunya, using serologic testing and polymerase chain reaction (PCR), the Eurosurveillance report says. In addition, the virus was detected in local Aedes albopictus mosquitoes, also known as tiger mosquitoes, by PCR. CDC information on A albopictushttp://www.cdc.gov/ncidod/dvbid/arbor/albopic_new.htm
Editor’s note: This story was updated Aug 7 to include information about the start of influenza vaccine shipments by Novartis.Aug 6, 2008 (CIDRAP News) – The six companies that make influenza vaccine for the US market have won federal approval for their version of this year’s vaccine, in which all three flu strains used in last year’s product have been replaced, the Food and Drug Administration (FDA) announced yesterday.The FDA announcement clears the way for marketing of the vaccines. At least three vaccine makers have begun shipping vaccine to distributors and providers, according to recent company announcements.The six manufacturers and their vaccines are CSL Limited, Afluria; GlaoxSmithKline Biologicals, Fluarix; ID Biomedical Corp. of Quebec (a unit of GlaxoSmithKline), FluLaval; MedImmune, FluMist; Novartis Vaccines and Diagnostics, Fluvirin; and Sanofi Pasteur, Fluzone.In the wake of a relatively poor match between the vaccine and circulating flu strains last season, experts at the World Health Organization and the FDA in February recommended changing all three strains of virus used in the vaccine. In most years only one or two of the three strains are changed.”One of the biggest challenges in the fight against influenza is producing new vaccines every year,” Jesse Goodman, MD, MPH, director of the FDA’s Center for Biologics Evaluation and Research, said in a news release. “There is no other instance where new vaccines must be made every year.”Two of the three strains in the 2008-09 vaccine are included in vaccines now being used in the Southern Hemisphere, where the flu season is under way, the FDA noted.The decision to change all three strains in the vaccine had generated some concern about possible production delays or low yields of the viruses, which are grown in eggs. But Curtis Allen, a spokesman for the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention (CDC) in Atlanta, said today he hasn’t heard of any problems growing the strains.”Vaccine production is always fraught with risk and anywhere along the line things can go wrong, but so far they have not, and we’re looking forward to a season with adequate supplies of vaccine,” Allen told CIDRAP News.At a meeting in May, manufacturers estimated they would produce a record total of 143 million to 146 million doses of flu vaccine for the US market this year. Allen said the estimates of vaccine production have not changed since then. Last year 140 million doses were produced.Allen listed the manufacturers’ production estimates as follows: Sanofi Pasteur, 50 million doses; GlaxoSmithKline (including ID Biomedical), 35 million to 38 million; MedImmune, 12 million; Novartis, 40 million; and CSL, 6 million.Sanofi announced Aug 1 that it had begun shipping the first 1.3 million doses of Fluzone. “Vaccine shipments to healthcare providers and to the [CDC] for distribution through the Vaccines for Children Program will continue through the fall and are planned to be completed in October,” the company said in a news release.The statement indicated that replacing all three strains of virus has not caused any major production problems.”Introduction of three new strains for the influenza vaccine was unprecedented and could have resulted in a low yield or delay given our tight production timeline. Despite these challenges, we are pleased that once again Sanofi Pasteur has demonstrated its reliability in supplying Fluzone vaccine to the US market,” said Wayne Pisano, the company’s president and chief executive officer, in the news release.MedImmune announced yesterday that shipments of FluMist, a nasal-spray vaccine that uses a weakened form of live virus, had begun on Jul 31. In a news release, the company affirmed that it plans to produce about 12 million doses, a record number.FluMist will be available at some retail pharmacies and supermarkets and in nearly 200 school-based vaccination programs and university health centers, the company said. In addition, the federal government, as in past years, is buying some doses for use in military personnel, officials said.Novartis announced Aug 7 that it has begun shipping Fluvirin to US healthcare providers. The company said it expects to deliver 20 million doses by the end of September and aims to deliver the remaining 20 million by Oct 31. Officials said the company has added a second manufacturing facility, located in Rosia, Italy, to help supply flu vaccine earlier in the season. The firm’s other facility is in Liverpool, England.”Despite the new composition [of the vaccine], Novartis made sure we were able to deliver a timely and robust supply of influenza vaccine this year,” said Rajiv De Silva, president of Novartis Vaccines in the US, in a news release.This is the first year the CDC is formally recommending flu shots for school-age children, adding about 30 million people to the ranks of those targeted for vaccination. Allen said the total number of those targeted for vaccination—including people at risk for serious flu complications and their close contacts—is about 258 million, or roughly 84% of the population.See also: Aug 5 FDA news releasehttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116933.htmFDA page with chart of vaccine lot releaseshttp://www.fda.gov/cber/flu/flu2008.htmAug 4 MedImmune news releaseAug 1 Sanofi Pasteur news releasehttp://www.vaccineplace.com/docs/first_shipment_release.pdfMay 13 CIDRAP News story “Flu experts try to ensure record vaccine doses get used”Feb 22 CIDRAP News story “FDA endorses overhaul for 2008-09 flu vaccine”
Virtuoso Travel Week in Las Vegas is the most important tourist event on the American continent, which is held every year in August and brings together cream of cream world luxury tourism. Exactly the 29th Virtuoso Travel Week recorded a record attendance – 5.670 participants from 103 countries, of which 2.714 were travel agents and 2.404 preferential partners.According to the CNTB, representatives of the CNTB Head Office and the CNTB New York office held numerous meetings with tour operators, travel agencies and other travel advisors, as well as cruising companies from the USA, Canada and Latin America and introduced them to the Croatian tourist offer, the role and activities of the CNTB and opportunities for cooperation in order to raise awareness of Croatia as an attractive and safe European and Mediterranean destination and increase tourist traffic from these markets.Membership and activities in cooperation with Virtuos are a priority for the promotion of Croatia, growth of tourist traffic, increasing the competitiveness of the offer and improving the quality of service and positioning Croatia on the map of world luxury destinations, the CNTB points out. Istria, Kvarner Tourist Board, Split-Dalmatia County Tourist Board, Dubrovnik-Neretva County Tourist Board and Virtuoso representatives of the Croatian tourism industry, Croatia is among the most sought after Virtuoso destinations with a growth in demand of about 25%.Lošinj Hotels & Villas became a new member of VirtuosThis year’s Virtuoso Travel week is extremely important for Croatia because we got a new member of Virtuoso, Boutique Hotel Alhambra – Lošinj Hotels & Villas, which is the biggest recognition for the last three years of demanding but very productive cooperation with Virtuoso. In addition to the CNTB and the Alhambra Hotel, the Croatian members of Virtuos are: Calvados Club, Fortuna Travel, Hotel Villa Dubrovnik and Le Meridien Lav Hotel.A big surprise of Virtuoso Travel Week is the recognition of the CNTB for successful cooperation and the proclamation of the CNTB Representative Ina Ina Rodin as the Ambassador of the Year of Virtuos and the awarding of the eponymous award during the 2017 Virtuoso Alliances meeting.With more than 16 tourism advisors worldwide and a portfolio of almost 1.700 partners (hotels and resorts, airlines, cruise companies, onsite travel agencies and tourist boards) and with an annual turnover of more than 21 billion US dollars, Virtuos is the most important organization in the luxury travel segment.Authenticity and experience One of Virtuoso’s unofficial slogans, as Matthew D. Upchurch points out, is the CEO next “A Virtuoso offers what you cannot see, but will feel forever.“It is precisely our greatest value that is our incredible diversity and authenticity, and yet on the other hand we continue to sell sun and sea. We are full of experiences, our authentic stories, and the motive of the trip is to get to know new ways and culture of living. The biggest responsibility lies with the local tourist boards, which unfortunately do not develop strategically or sustainably. Tourist destinations (cities, counties, so-called) develop local tourism, ie tourist destinations, while CNTB and MINT are on a global level and as a platform or extended arm to the entire sector.Everyone has known and talked for years, even Virtuoso, and it has always been so, tourism is emotions, experiences and stories. Let’s tell stories
Public bicycles are an increasingly popular form of transport in 14 Croatian cities and municipalities, and today Vukovar joined the company and thus became the fifteenth and easternmost city in Croatia to introduce the Nextbike system of public bicycles.After the official presentation of the project, a test ride on public bicycles from the city center to Borovo naselje followed, with a short refreshment at Ina’s station. The Nextbike system of public bicycles in Croatia has 20.500 registered users, significantly reduces emissions, traffic jams, noise and parking problems, and cycling has a positive effect on mental and physical health.But the most important thing is that from today, Vukovar residents and all tourists can combine train, bus and public bicycles and thus travel faster, healthier and cheaper while protecting the environment in which we live – through integrated public transport. “In recent years, to the delight of the citizens, Vukovar has received several bicycle paths, of which the most important is certainly the one that is still under construction, ie the bicycle path along the state road D2 in the part of Kudeljarska and Priljevo streets. This is exactly the route we took on the new public bicycles and which is certainly the most important route because it connects the center of Vukovar and Borovo Naselje. Our citizens have a culture of cycling, so I am convinced that this initiative will be very well received. With the new bicycle path and bicycles in the public transport service, we will improve the connection of all parts of Vukovar and at the same time reduce traffic jams. This project is just one in a series of steps we are taking to raise the quality of life of our fellow citizens, but also to present our city in a new European spirit that will surely meet the approval of both citizens and tourists who see Vukovar as the central destination of the Croatian Danube region., ”Said Vukovar Mayor Ivan Penava.This greenest, healthiest and most cost-effective form of public urban transport is fully in line with EU directives and the vision and plans of the City of Vukovar related to sustainable development. Beautiful Vukovar, as the civilizational starting point of Europe in which culture developed for five thousand years and the city that suffered the greatest war destruction, needs projects facing the future. Development is a matter of piety, but also the fact that Vukovar citizens like all citizens of this country want to finally stand by their European neighbors, and this is possible only with continuous investment in sustainable construction, education, employment and sustainable mobility that connect all segments of society.Nextbike provides citizens, students and tourists with the most affordable, fastest, healthiest and most fun transportation. A user who registers nextbike bikes can use them in more than 140 cities around the world. Nextbike is ready to welcome new cities and companies that invest in sustainable mobility and continuously invests in new technologies and improving the user experience, says Krešimir Dvorski, director of the Public Bicycle System, adding that in order to feel safer in traffic, Nextbike organizes several cycling school and encourages cities to improve cycling infrastructure. “Launching a public bicycle system in Vukovar was our great wish a few years ago when we were thinking about how to connect the far east of Croatia with all other major county centers. By combining different forms of public transport, each of us can quickly, easily and conveniently get from point A to point B without owning a car. We thank the City of Vukovar and INA as the general sponsor of the system maintenance for recognizing the importance of the project for the local community. Thanks to them, from today, the people of Vukovar can enjoy all the benefits that the public bicycle system brings them”Dvorski concluded.